PD-1 is a regulator of virus-specific CD8+ T cell survival in HIV infection

Cited by (889)

Items 601–700 of 889

1. Engineered Antigen-Specific T Cells Secreting Broadly Neutralizing Antibodies: Combining Innate and Adaptive Immune Response against HIV
   Allison B. Powell, Yanqin Ren, Maria Korom, Devin Saunders, Patrick J. Hanley, Harris Goldstein, Douglas F. Nixon, Catherine M. Bollard, Rebecca M. Lynch, Richard Brad Jones et al. · 2020 · Molecular Therapy — Methods & Clinical Development
2. DNA demethylation in PD-1 gene promoter induced by 5-azacytidine activates PD-1 expression on Molt-4 cells
   Min Zhang, Xin Q. Xiao, Yong Fang Jiang, Yun Liang, Min Peng, Xu Yun, Guozhong Gong · 2011 · Cellular Immunology
3. A High Viral Burden Predicts the Loss of CD8 T-Cell Responses Specific for Subdominant Gag Epitopes during Chronic Human Immunodeficiency Virus Infection
   Christof Geldmacher, Clive M. Gray, Martha Nason, Jeffrey R. Currier, Antelmo Haule, Lilian Njovu, Steffen Geis, Oliver Ingo Hoffmann, Leonard Maboko, Andreas Meyerhans et al. · 2007 · Journal of Virology
4. Regulatory Mechanisms and Therapeutic Targeting of PD-L1 Trafficking and Stability in Cancer Immunotherapy
   Muralidharan Mani, Jeong Woo Park, Thomas F.J. Martin · 2025 · Cancers
5. Hepatocellular cancer therapy in patients with HIV infection: Disparities in cancer care, trials enrolment, and cancer-related research
   Francesca Negri, Gabriele Missale, Anna Degli Antoni, Camillo Porta · 2021 · Translational Oncology
6. Distinct effects of treatment with two different interferon-alpha subtypes on HIV-1-associated T-cell activation and dysfunction in humanized mice
   Saurav S. Rout, Yunyun Di, Ulf Dittmer, Kathrin Sutter, Kerry J. Lavender · 2021 · AIDS
7. Kynurenine 3-Monooxygenase Inhibition during Acute Simian Immunodeficiency Virus Infection Lowers PD-1 Expression and Improves Post–Combination Antiretroviral Therapy CD4+ T Cell Counts and Body Weight
   Louise A. Swainson, Haelee Ahn, Priya Pajanirassa, Vinod K. Khetarpal, Claire Deléage, Jacob D. Estes, Peter W. Hunt, Ignacio Muñoz-Sanjuán, J M McCune · 2019 · The Journal of Immunology
8. Persistent chronic immune activation in HIV/HBV‐coinfected patients after antiretroviral therapy
   Yaozu He, Weiping Cai, Jingliang Chen, Fengyu Hu, Feng Li, Weiyin Lin, Yonghong Li, Xiejie Chen, Xiaoping Tang, Linghua Li · 2021 · Journal of Viral Hepatitis
9. Active PD-L1 incorporation within HIV virions functionally impairs T follicular helper cells
   Olivia Muñoz, Riddhima Banga, Rachel Schelling, Francesco A. Procopio, Andrea Mastrángelo, Pauline Nortier, Khalid Ohmiti, Jean Daraspe, Matthias L. Cavassini, Craig W. Fenwick et al. · 2022 · PLoS Pathogens
10. Activation and Exhaustion of Adaptive Immune Cells in Hepatitis B Infection
    Dimpu Gogoi, Biswajyoti Borkakoty, Dipankar Biswas, Jagadish Mahanta · 2015 · Viral Immunology
11. Role of Regulatory T Cells and Inhibitory Molecules in the Development of Immune Exhaustion During Human Immunodeficiency Virus Type 1 Infection
    Sandra Milena González, Wildeman Zapata, Marı́a Teresa Rugeles · 2015 · Viral Immunology
12. Effect of IL-7 Therapy on Phospho-Ribosomal Protein S6 and TRAF1 Expression in HIV-Specific CD8 T Cells in Patients Receiving Antiretroviral Therapy
    Chao Wang, Maria I. Edilova, Lisa E. Wagar, Shariq Mujib, Meromit Singer, Nicole Flore Bernard, Thérèse Croughs, Michael M. Lederman, Irini Sereti, Margaret A. Fischl et al. · 2017 · The Journal of Immunology
13. Complement-Opsonized HIV-1 Alters Cross Talk Between Dendritic Cells and Natural Killer (NK) Cells to Inhibit NK Killing and to Upregulate PD-1, CXCR3, and CCR4 on T Cells
    Rada Ellegård, Mohammad Khalid, Cecilia Svanberg, Hanna Holgersson, Ylva Thorén, Mirja Karolina Wittgren, Jorma Hinkula, Sofia N. Nyström, Esaki Muthu Shankar, Marie Larsson · 2018 · Frontiers in Immunology
14. Increased levels of soluble co-stimulatory molecule PD-L1 (B7-H1) in the plasma of viraemic HIV-1+ individuals
    Ana de León-Flores, Perla M. Del Río Estrada, L.X. Álvarez-García, Elvira Pitén-Isidro, Gustavo Reyes‐Terán · 2018 · Immunology Letters
15. Role of cytokine agonists and immune checkpoint inhibitors toward HIV remission
    Timothy N. Hoang, Mirko Paiardini · 2018 · Current Opinion in HIV and AIDS
16. PD-1 Upregulation Is Associated with Exhaustion of Regulatory T Cells and Reflects Immune Activation in HIV-1-Infected Individuals
    Jian Xiao, Lifeng Zhang, Yuan Dong, Xian Liu, Lishan Peng, Yang Yang, Ying Wang · 2019 · AIDS Research and Human Retroviruses
17. Plasticity in T-cell mitochondrial metabolism: A necessary peacekeeper during the troubled times of persistent HIV-1 infection
    Hamza Loucif, Xavier Dagenais-Lussier, Cherifa Beji, Roman Telittchenko, Jean‐Pierre Routy, Julien van Grevenynghe · 2020 · Cytokine & Growth Factor Reviews
18. The latency-reversing agent HODHBt synergizes with IL-15 to enhance cytotoxic function of HIV-specific T cells
    Dennis C. Copertino, Carissa S. Holmberg, Jared Weiler, Adam R. Ward, J. Natalie Howard, Callie Levinger, Alina P.S. Pang, Michael J. Corley, Friederike Dündar, Paul Zumbo et al. · 2023 · JCI Insight
19. Viral diversity limits immune diversity in asymptomatic phase of HIV infection
    Shingo Iwami, Shinji Nakaoka, Yasuhiro Takeuchi · 2008 · Theoretical Population Biology
20. Maintaining the balance: Costimulatory TNFRs and control of HIV
    Chao Wang, Tania H. Watts · 2012 · Cytokine & Growth Factor Reviews
21. Specific and high-affinity binding of tetramerized PD-L1 extracellular domain to PD-1-expressing cells: possible application to enhance T cell function
    Seigo Terawaki, Yoshimasa Tanaka, Tomokazu Nagakura, T. Hayashi, S. Shibayama, K. Muroi, Taku Okazaki, Bunzo Mikami, David N. Garboczi, T Honjo et al. · 2007 · International Immunology
22. Hepatoma cells up-regulate expression of programmed cell death-1 on T cells
    Ji Chen, Xuejie Wu, Guiqiang Wang · 2008 · World Journal of Gastroenterology
23. Major influence of CD4 count at the initiation of cART on viral and immunological reservoir constitution in HIV-1 infected patients
    Anne-Emmanuelle Depincé-Berger, Delphine Vergnon-Miszczycha, Alexandre Girard, Anne Fresard, Élisabeth Botelho-Nevers, Claude Lambert, Émilie Del Tedesco, Christian Genin, Bruno Pozzetto, F. Lucht et al. · 2016 · Retrovirology
24. Immunologic Predictors of Late Cytomegalovirus Disease after Solid Organ Transplantation—An Elusive Goal?
    Michael Boeckh, Stanley R. Riddell · 2007 · The Journal of Infectious Diseases
25. Budigalimab, an anti-PD-1 inhibitor, for people living with HIV-1: a randomized, placebo-controlled phase 1b study
    Moti N. Ramgopal, Jacob Paul Lalezari, Ana Gabriela Pires dos Santos, Preethi Krishnan, Tanaya R. Vaidya, Fei Zhou, Heide Betman, Patrick K. Dorr, Nael Mohamed Mostafa, Maria Luisa Alcaide et al. · 2025 · Nature Medicine
26. Costimulation Immunotherapy in Infectious Diseases
    Manzoor Ahmad Mir · 2015 · Elsevier eBooks
27. Peptide–MHC multimer-based monitoring of CD8 T-cells in HIV-1 infection and AIDS vaccine development
    Alena Reguzova, Л. И. Карпенко, Ludmila V. Mechetina, Igor M. Belyakov · 2014 · Expert Review of Vaccines
28. PD-1 mRNA expression in peripheral blood cells and its modulation characteristics in cancer patients
    Wei Wang, Ge Shen, Shikai Wu, Shiping Song, Yanli Ni, Zhuoyao Suo, Xiangying Meng, Dan Li, Lin Zhou, Rimin Hao et al. · 2017 · Oncotarget
29. An M2 Rather than a TH2 Response Contributes to Better Protection against Latency Reactivation following Ocular Infection of Naive Mice with a Recombinant Herpes Simplex Virus 1 Expressing Murine Interleukin-4
    Dhong Hyun Lee, Homayon Ghiasi · 2018 · Journal of Virology
30. T‐cell heterogeneity, progenitor–progeny relationships, and function during latent and chronic viral infections
    Ioana Sandu, Annette Oxenius · 2023 · Immunological Reviews
31. Human bone marrow contains a subset of quiescent early memory CD8+ T cells characterized by high CD127 expression and efflux capacity
    Robert Kudernatsch, Anne Letsch, Manuel Guerreiro, Madlen Löbel, Sandra Bauer, Hans‐Dieter Volk, Carmen Scheibenbogen · 2014 · European Journal of Immunology
32. High Production Rates Sustain In Vivo Levels of PD-1 high Simian Immunodeficiency Virus-Specific CD8 T Cells in the Face of Rapid Clearance
    Constantinos Petrovas, Takuya Yamamoto, David A. Price, Srinivas S. Rao, Nichole R. Klatt, Jason M. Brenchley, Daniel C. Douek, Emma Gostick D, B. Angermann, Zvi Grossman et al. · 2013 · Journal of Virology
33. DifferentIn VivoEffects of HIV-1 Immunodominant Epitope-Specific Cytotoxic T Lymphocytes on Selection of Escape Mutant Viruses
    Hirokazu Koizumi, Masao Hashimoto, Mamoru Fujiwara, Hayato Murakoshi, Takayuki Chikata, Mohamed Ali Borghan, Atsuko Hachiya, Yuka Kawashima, Hiroshi Takata, Takamasa Ueno et al. · 2010 · Journal of Virology
34. Inhibitors of B7–CD28 Costimulation in Urologic Malignancies
    Robert Houston Thompson, Eugene D. Kwon, James Patrick Allison · 2008 · Immunotherapy
35. Pattern Recognition Receptor Ligands as an Emerging Therapeutic Agent for Latent HIV-1 Infection
    Shokichi Takahama, Takuya Yamamoto · 2020 · Frontiers in Cellular and Infection Microbiology
36. Functional Characteristics and Phenotypic Plasticity of CD57+PD1− CD4 T Cells and Their Relationship with Transplant Immunosuppression
    Brian I. Shaw, Jaclyn R. Espinosa, Linda Stempora, Allison Miller, Bartley Adams, Allan D. Kirk · 2021 · The Journal of Immunology
37. Cloning and identification of porcine programmed death 1
    Jinmei Peng, Zhi‐Jun Tian, Heng-Gui Liu, Tongqing An, Yanjun Zhou, Yao Wang, Dengyun Li, Jiazeng Chen, Yongqian Yang, Guangzhi Tong · 2010 · Veterinary Immunology and Immunopathology
38. Interleukin-7 in Patients With Chronic Hepatitis B May Have Effect on T Follicular Helper Cells and Specific Cellular Immunity
    Hua Zhong, Gu Xibing, Dai Yaping, Zheng Wang, Fu Decai, Guo Xiaoye, Hang-Yuan Wu, Wang Dong, Zhonghua Lu · 2016 · Hepatitis Monthly
39. 4-1BB Enhances Proliferation of Beryllium-Specific T Cells in the Lung of Subjects with Chronic Beryllium Disease
    Douglas G. Mack, Allison K. Lanham, Brent E. Palmer, Lisa A. Maier, Tania H. Watts, Andrew P. Fontenot · 2008 · The Journal of Immunology
40. Renaissance of antiviral CD8+ T cell immunity in vaccination and disease
    Victor Appay, Takuya Yamamoto, Asier Sáez‐Cirión · 2026 · Nature reviews. Immunology
41. Inhibitory and Stimulatory Effects of IL-32 on HIV-1 Infection
    Hesham Nasser, Naofumi Takahashi, Youssef M. Eltalkhawy, Omnia Reda, Sameh E. Lotfi, Kanako Nasu, Jun-ichi Sakuragi, Shinya Suzu · 2022 · The Journal of Immunology
42. Immunopathogenesis of AIDS
    Alexandra M. Ortiz, Guido Silvestri · 2009 · Current Infectious Disease Reports
43. Role of common gamma chain utilizing cytokines for immune reconstitution in HIV infection
    Savita G. Pahwa · 2007 · Immunologic Research
44. Recipient-Derived Cells after Cord Blood Transplantation: Dynamics Elucidated by Multicolor FACS, Reflecting Graft Failure and Relapse
    Nobukazu Watanabe, Satoshi Takahashi, Masayuki Ishige, Yumiko Ishii, Jun Ooi, Akira Tomonari, Nobuhiro Tsukada, Takaaki Konuma, Seiko Kato, Aki Sato et al. · 2008 · Transplantation and Cellular Therapy
45. Update on hepatitis C virus-specific immunity
    Donatella Ciuffreda, Arthur Y. Kim · 2011 · Current Opinion in HIV and AIDS
46. T-cell and B-cell perturbations identify distinct differences in HIV-2 compared with HIV-1-induced immunodeficiency
    Bo Langhoff Hønge, Mikkel Steen Petersen, Sanne Jespersen, Cándida Medina, David Te, Bertram Dalskov Kjerulff, Thomas Engell-Sørensen, Tina Vasehus Madsen, Alex Lund Laursen, Christian Morberg Wejse et al. · 2019 · AIDS
47. Peculiar Phenotypic and Cytotoxic Features of Pulmonary Mucosal CD8 T Cells in People Living with HIV Receiving Long-Term Antiretroviral Therapy
    O. Méziane, Y. Alexandrova, R. Olivenstein, F. Dupuy, Syim Salahuddin, E. Thomson, M. Orlova, E. Schurr, P. Ancuța, M. Durand et al. · 2020 · Journal of Immunology
48. Monoclonal antibodies specific to human Δ42PD1: A novel immunoregulator potentially involved in HIV-1 and tumor pathogenesis
    Lin Zhang Cheng, Xian Tang, Li Liu, Jie Peng, Kenji Nishiura, Allen Ka Loon Cheung, Jia Guo, Xilin Wu, Hang Ying Tang, Minghui An et al. · 2015 · mAbs
49. The role of cytotoxic T cells in IgG4-related dacryoadenitis and sialadenitis, the so-called Mikulicz's disease
    Tetsuya Tabeya, Motohisa Yamamoto, Yasuyoshi Naishiro, Keisuke Ishigami, Yui Shimizu, Hidetaka Yajima, Chisako Suzuki, Nobuhiko Seki, Kenichi Takano, Tetsuo Himi et al. · 2014 · Modern Rheumatology
50. Acute HIV infection: the impact of anti-retroviral treatment on cellular immune responses
    Charles B. Hicks, Cynthia L. Gay, Guido Ferrari · 2007 · Clinical & Experimental Immunology
51. Targeting the TCR signaling checkpoint: a therapeutic strategy to reactivate memory T cells in the tumor microenvironment
    Michelle R. Simpson-Abelson, Richard B. Bankert · 2008 · Expert Opinion on Therapeutic Targets
52. Differentiation and Function of Follicular CD8 T Cells During Human Immunodeficiency Virus Infection
    Minglu Xiao, Xiangyu Chen, Ran He, Lilin Ye · 2018 · Frontiers in Immunology
53. Dendritic Cell Differentiation and Maturation in the Presence of HIV Type 2 Envelope
    Rita Cavaleiro, António P. Baptista, Russell B. Foxall, Rui M. M. Victorino, Ana E. Sousa · 2009 · AIDS Research and Human Retroviruses
54. Monitoring of CMV-specific T-cell levels after organ transplantation / Monitoring CMV-spezifischer T-Zellen nach Organtransplantation
    Martina Sester, Barbara Christine Gärtner, Urban Sester · 2008 · Journal of Laboratory Medicine
55. PD-1/PD-L1 pathway inhibition to restore effector functions in exhausted CD8+ T cells: chances, limitations and potential risks
    Priya Veluswamy, Dunja Bruder · 2018 · Translational Cancer Research
56. The impact of MDSCs on the efficacy of preventive and therapeutic HIV vaccines
    Mahmoud Mohammad Yaseen, Nizar Mohammad Abuharfeil, Homa Darmani · 2021 · Cellular Immunology
57. Progress Towards a Therapeutic HIV DNA Vaccine
    Paul V. Munson · 2022 · Expert Review of Vaccines
58. R5-SHIV Induces Multiple Defects in T Cell Function during Early Infection of Rhesus Macaques Including Accumulation of T Reg Cells in Lymph Nodes
    Michael Santosuosso, Elda Righi, E. David Hill, Pierre R Leblanc, Brett Kodish, Hari N. Mylvaganam, Nagadenahalli Byrareddy Siddappa, Liljana Stevceva, Shiu-Lok Hu, Musie S Ghebremichael et al. · 2011 · PLoS ONE
59. Foxp3+Helios+ regulatory T cells are associated with monocyte subsets and their PD-1 expression during acute HIV-1 infection
    Lifeng Liu, Qiuyue Zhang, Peng Chen, Na Guo, Aixin Song, Xiaojie Huang, Wei Xia, Li Li, Christiane Moog, Hao Wu et al. · 2019 · BMC Immunology
60. Innate antiviral and immune functions associated with the HIV reservoir decay after anti-PD-1 therapy
    Aarthi Talla, Joao L. L. C. Azevedo, Muhammad Bilal Latif, Ana Beatriz Enriquez, Gabriela Pacheco Sanchez, Adam Nicolas Pelletier, Saswat Kumar Bal, Sangeeta Kumari, Viviane Schuch, Khader Ghneim et al. · 2026 · Nature Medicine
61. Heteroclitic peptides enhance human immunodeficiency virus-specific CD8+ T cell responses
    Krista H. Gladney, Julia Pohling, Natasha A. Hollett, Katrin Zipperlen, Maureen Gallant, Michael D. Grant · 2012 · Vaccine
62. IL-2 immunotherapy in chronically SIV-infected Rhesus Macaques
    Julie Garibal, Mireille Laforge, Ricardo Silvestre, Shahul Mouhamad, L. Campillo-Gimenez, Yves Lévy, Jérôme Estaquier · 2012 · Virology Journal
63. Cell cycle checkpoints and pathogenesis of HIV-1 infection: a brief overview
    Kesava Rao Venkata Kurapati, Thangavel Samikkannu, Venkata Subba Rao Atluri, Madhavan Nair · 2014 · Journal of Basic and Clinical Physiology and Pharmacology
64. Evaluation of antiviral T cell responses and TSCM cells in volunteers enrolled in a phase I HIV-1 subtype C prophylactic vaccine trial in India
    Sivasankaran Munusamy Ponnan, Peter Hayes, Natalia Fernández, Kannan Thiruvengadam, Sathyamurthi Pattabiram, Manohar Nesakumar, Ashokkumar Srinivasan, Sujitha Kathirvel, Janani Shankar, Rajat Goyal et al. · 2020 · PLoS ONE
65. Rational design of a Nivolumab-based ANTI-PD-1 single chain variable fragment that blocks the interaction between PD-1 expressed on T-CELLS and PD-L1 ON CHO cells
    Jong Shin, Siavash Raissi, Paul Phelan, Peter A. Bullock · 2022 · Protein Expression and Purification
66. Programmed Death 1 (PD-1) is involved in the development of proliferative diabetic retinopathy by mediating activation-induced apoptosis.
    Mengyuan Fang, Qianli Meng, Haike Guo, Liya Wang, Zhaoxia Zhao, Liang Zhang, Jian Kuang, Ying Cui, Liping Mai, Jie-Ning Zhu · 2015 · Europe PMC (PubMed Central)
67. Polyfunctional analysis of Gag and Nef specific CD8+ T-cell responses in HIV-1 infected Indian individuals
    Sanjay Mendiratta, Madhu Vajpayee, Kamalika Mojumdar, Neeraj K. Chauhan, Vishnubhatla Sreenivas · 2010 · Vaccine
68. Immunologic Control of HIV-1: What Have We Learned and Can We Induce It?
    Daniel C. Rogan, Mark Connors · 2021 · Current HIV/AIDS Reports
69. So Pathogenic or So What?—A Brief Overview of SIV Pathogenesis with an Emphasis on Cure Research
    Adam J. Kleinman, Ivona Pandrea, Cristian Apetrei · 2022 · Viruses
70. Monitoring clinical trials of therapeutic vaccines in HIV infection: role of treatment interruption
    Michael M. Lederman, Adam Penn‐Nicholson, Shelley F. Stone, Scott F. Sieg, Benigno A. Rodriguez · 2007 · Current Opinion in HIV and AIDS
71. Suppressive activity of regulatory T cells correlates with high CD4+ T-cell counts and low T-cell activation during chronic simian immunodeficiency virus infection
    Ingrid Karlsson, Benoît Malleret, Patricia Brochard, Benoît Delache, Julien Calvo, Roger Le Grand, Bruno Vaslin · 2010 · AIDS
72. Human immunodeficiency virus vaccines
    Marc P Girard, Wayne Chester Koff · 2008 · Elsevier eBooks
73. Combination rhIL-15 and Anti-PD-L1 (Avelumab) Enhances HIVGag-Specific CD8 T-Cell Function
    Bruktawit A. Goshu, Hui Chen, Maha Moussa, Jie Cheng, Marta Catálfamo · 2020 · The Journal of Infectious Diseases
74. Premature skewing of T cell receptor clonality and delayed memory expansion in HIV-exposed infants
    Sonwabile Dzanibe, Aaron J. Wilk, Susan Canny, Thanmayi Ranganath, Berenice Alinde, Florian Rubelt, Huang Huang, Mark M. Davis, Susan Holmes, Heather B. Jaspan et al. · 2024 · Nature Communications
75. Chronic viral infection alters PD-1 locus subnuclear localization in cytotoxic CD8+ T cells
    Catarina Sacristán, Ben Youngblood, Peiyuan Lu, Alexander P. R. Bally, Jean Xu, Katelyn McGary, Susannah L. Hewitt, Jeremy M. Boss, Jane A. Skok, Rafi Ahmed et al. · 2024 · Cell Reports
76. Collaboration of a Detrimental HLA-B*35:01 Allele with HLA-A*24:02 in Coevolution of HIV-1 with T Cells Leading to Poorer Clinical Outcomes
    Nozomi Kuse, Hayato Murakoshi, Tomohiro Akahoshi, Takayuki Chikata, Katherine L. James, Hiroyuki Gatanaga, Sarah Rowland‐Jones, Shinichi Oka, Masafumi Takiguchi · 2021 · Journal of Virology
77. Interleukin 15 upregulates the expression of PD-1 and TIM-3 on CD4+ and CD8+ T cells.
    Mohamad Saifudin Hakim, Rizka Oktarianti Ainun Jariah, Michelle Spaan, André Boonstra · 2020 · PubMed Central
78. Enhancing Human Immunodeficiency Virus-Specific CD8+ T Cell Responses with Heteroclitic Peptides
    Adeolu Adegoke, Michael D. Grant · 2015 · Frontiers in Immunology
79. Modulating Co-Stimulation
    Vissia Viglietta, Samia Joseph Khoury · 2007 · Neurotherapeutics
80. Developing Combined HIV Vaccine Strategies for a Functional Cure
    Alessandra Noto, Lydie Trautmann · 2013 · Vaccines
81. Inhibitory receptors: whose side are they on?
    Alison Crawford, E. John Wherry · 2007 · Nature Immunology
82. CD8+ T cells specific for both persistent and non-persistent viruses display distinct differentiation phenotypes but have similar level of PD-1 expression in healthy Chinese individuals
    Xian‐Hui He, Jia Qian-tao, Fengyao Li, Mark Saltis, Yi Liu, Lihui Xu, Qingbing Zha · 2007 · Clinical Immunology
83. Host-directed approaches in the pursuit of a cure for HIV
    Rory A. Shepherd, Kiho Tanaka, Hannah A. D. King, Maya Dyveke Schou, Oscar H. Lloyd Williams, Youry Kim, Michael Roche, Sharon R. Lewin · 2025 · Antiviral Research
84. Chronic Inflammation in HIV Pathogenesis: Effects on Immune Cells, Organ Systems, and Systemic Consequences
    D. Lewis, Jacob P. Couturier · 2018 · Translational Inflammation
85. Control of Simian Immunodeficiency Virus Infection in Prophylactically Vaccinated, Antiretroviral Treatment-Naive Macaques Is Required for the Most Efficacious CD8 T Cell Response during Treatment with the Interleukin-15 Superagonist N-803
    Amy L. Ellis-Connell, Alexis J. Balgeman, Olivia E. Harwood, Ryan V. Moriarty, Jeffrey T. Safrit, Andrea M. Weiler, Thomas C. Friedrich, Shelby L. O’Connor · 2022 · Journal of Virology
86. Double Positive CD4+CD8+ (DP) T-Cells Display Distinct Exhaustion Phenotype in Chronic Hepatitis C
    Anna Maria Kochanowicz, Sylwia Osuch, Hanna Berak, Aleksandra Kumorek, Kamila Caraballo Cortés · 2023 · Cells
87. Anti-PD-1-Targeted Therapies Focusing on Lymphatic Malignancies: Biological Rationale, Clinical Challenges and Opportunities
    Meirav Kedmi, Abraham Avigdor, Arnon Nagler · 2014 · Acta Haematologica
88. Enhancing immune responses to limit chronic immune activation during SIV
    Jacob D. Estes · 2012 · Journal of Clinical Investigation
89. Overexpression of PD‐L1 causes germ cells to slough from mouse seminiferous tubules via the PD‐L1/PD‐L1 interaction
    Lian Fang, Rui Feng, Weiye Liang, Fang‐Fang Liu, Ganlan Bian, Caiyong Yu, Hongmin Guo, Yihui Cao, Mingkai Liu, Jia Zuo et al. · 2022 · Journal of Cellular and Molecular Medicine
90. Epitope Specificity Delimits the Functional Capabilities of Vaccine-Induced CD8 T Cell Populations
    Brenna J. Hill, Patricia A. Darrah, Zachary S. Ende, David R. Ambrozak, Kylie M. Quinn, Samuel W. Darko, Emma Gostick D, Linda Wooldridge, Hugo Antonius van den Berg, Vanessa Venturi et al. · 2014 · The Journal of Immunology
91. Investigational PD-1 inhibitors in HL and NHL and biomarkers for predictors of response and outcome
    Andrés Chang, Danielle Schlafer, Christopher R. Flowers, Pamela B. Allen · 2017 · Expert Opinion on Investigational Drugs
92. Recombinant Human Interleukin-15 and Anti-PD-L1 Combination Therapy Expands a CXCR3+PD1−/low CD8 T-Cell Subset in Simian Immunodeficiency Virus-Infected Rhesus Macaques
    Ping Chen, Hui Chen, Maha Moussa, Jie Cheng, Tong Li, Jing Qin, Jeffrey D. Lifson, Michael C. Sneller, Ludmila Krymskaya, Steven Godin et al. · 2019 · The Journal of Infectious Diseases
93. Emerging Concepts in the Immunopathogenesis
    Daniel C. Douek, Mario Roederer, Richard A. Koup · 2009
94. High expression of ACTL6A leads to poor prognosis of oral squamous cell carcinoma patients through promoting malignant progression
    Yi Liu, Yisha Liu, Ying Li, Tong Wang, Bolong Li, Xianchen Kong, Changyi Li · 2024 · Head & Neck
95. Pathophysiology of HIV and strategies to eliminate AIDS as a public health threat
    Omar Gustavo Sued, Tomás Martín Grosso · 2022 · Elsevier eBooks
96. CD8+ T-cell priming is quantitatively but not qualitatively impaired in people with HIV-1 on antiretroviral therapy
    Mariela Pires Cabral-Piccin, Olivia Briceño, Laura Papagno, Benjamin Liouville, Eoghann White, Federico Perdomo-Celis, Gaëlle Autaa, Stevenn Volant, Sian Llewellyn‐Lacey, Rémi Fromentin et al. · 2023 · AIDS
97. The CD27/CD70 pathway negatively regulates visceral adipose tissue-resident Th2 cells and controls metabolic homeostasis
    Kevin Englebert, Anaëlle Taquin, Abdulkader Azouz, Valérie Acolty, Sylvie Vande Velde, Marie Vanhollebeke, Hadrien Innes, Louis Boon, Tibor Keler, Oberdan Léo et al. · 2024 · Cell Reports
98. Co-infection with hepatitis B and human immunodeficiency virus: epidemiology, pathogenesis, and treatment
    Yaozu He, Weiyin Lin, Fei Gu, Xianglong Lan, Linghua Li · 2024 · Infectious Diseases & Immunity
99. Weak SARS-CoV-2-specific responses of TIGIT-expressing CD8+ T cells in people living with HIV after a third dose of a SARS-CoV-2 inactivated vaccine
    Junyan Jin, Xiuwen Wang, Yongzheng Li, Xiaodong Yang, Hu Wang, Xiaoxu Han, Jin Sun, Zhenglai Ma, Junyi Duan, Guanghui Zhang et al. · 2023 · Chinese Medical Journal
100. Immune checkpoint inhibitors and SARS-CoV2 infection
     Samaneh Abdolmohammadi‐Vahid, Behzad Baradaran, Ian Michael Adcock, Esmaeil Mortaz · 2024 · International Immunopharmacology